Europe Pharmaceutical Cro Market Size & Outlook, 2024-2030
Europe pharmaceutical cro market, 2018-2030 (US$M)
Related Markets
Europe pharmaceutical cro market highlights
- The Europe pharmaceutical cro market generated a revenue of USD 6,528.8 million in 2024.
- The market is expected to grow at a CAGR of 5.1% from 2025 to 2030.
- In terms of segment, clinical was the largest revenue generating type in 2024.
- Pre-Clinical is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Germany is expected to register the highest CAGR from 2025 to 2030.
Europe data book summary
| Market revenue in 2024 | USD 6,528.8 million |
| Market revenue in 2030 | USD 8,817.4 million |
| Growth rate | 5.1% (CAGR from 2024 to 2030) |
| Largest segment | Clinical |
| Fastest growing segment | Pre-Clinical |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Drug Discovery, Pre-Clinical, Clinical |
Other key industry trends
- In terms of revenue, Europe region accounted for 15.8% of the global pharmaceutical cro market in 2024.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 32,105.5 million by 2030.
Clinical was the largest segment with a revenue share of 75.71% in 2024. Horizon Databook has segmented the Europe pharmaceutical cro market based on drug discovery, pre-clinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.
Europe pharmaceutical CRO accounted for 15.84% market share in 2024 due to the presence of reputed pharmaceutical companies, numerous drug discoveries, and increased demand for CROs. In addition, many CROs specializing in drug discovery have their centers in European countries like the UK, Germany, and France, which is expected to contribute to market growth in this region.
Moreover, the growing trend of outsourcing services to European countries is expected to contribute to the increasing demand for pharmaceutical CRO in this region. The regional market is expected to be driven by a large patient population across Eastern & Western Europe and a centralized submission process for clinical trials.
In addition, rising demand for new drugs, the expansion of new facilities, and emerging R&D activities are changing market scenarios rapidly. For instance, in November 2023, private equity investor Henko Partners launched Astrum Contract Research Organization.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pharmaceutical CRO Market Scope
Pharmaceutical CRO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe pharmaceutical cro market size, by country, 2018-2030 (US$M)
Europe Pharmaceutical CRO Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
